Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
199 Cards in this Set
- Front
- Back
composition of chylomicron
|
80-90% triglyceride, 10-15% phospholipid, < 5% cholesterol
|
|
colipase
|
helps pancreateic lipase (which function sin associating with the lipid droplet) bind to micelles
|
|
purpose of the hydrophilic side of bile
|
allows for the emulsification property of bile
|
|
how is LPL (lipoprotein lipase) held to the vessel wall
|
by ionic interactions, can be displaced by heparin, useful to assess LPL activity
|
|
RBCs energy supply
|
RBCs uses only glucose, and therefore only glycolysis
|
|
brain energy supply
|
uses mostly glucose, never chylomicrons but will use ketones, use chylomicrons mostly for structure
|
|
what percent of bile is reabsorbed
|
80-90%
|
|
adipocytes and glucose utilization
|
needs insulin to have glucose enter adipocytes, does not undergo glycogen formation, responsible for producing fatty acids
|
|
how does insulin lower [glucose]
|
through glycogen synthesis (when well fed) and fatty acid synthesis
|
|
muscle and carbohydrates
|
responsible more so for using fatty acids
|
|
liver and carbohydrates
|
makes glycogen, goes through HMPS to make lots of NADPH and RNA and DNA synthesis, can use fatty acids and make them as well
|
|
sources of C2 in liver utilization of carbs
|
initially gets energy from fatty acids, then eventually through free glucose in the blood as the glucose levels begin to INC
|
|
where does glycerol come from
|
DHAP and glycerol kinase
|
|
where are the C2s used?
|
used in fatty acid synthesis, if saturated in the cycle, then can also use for cholesterol synthesis
|
|
vegetables and cholesterol
|
chol. not found in vegetables
|
|
dietary input and cholesterol levels
|
complete removal of cholesterol from diet only lowers [cholesterol] by 10-15%, the majority of the cholesterol comes from carbohydrate intake
|
|
normal blood glucose level
|
70-100%, 4mM, pretty constant with time
|
|
time course for the regulation of blood sugar
|
with time when last ate at t=0, ycogen degradation occurs at about 12-24 hours, early on there is also lipid degradation which is used up as well, spares blood sugar, amino acids are relatively low in concentration, fit in after glycogen degradation is almost all used up (is glucose sparring and utilizes gluconeogenesis), within 24 hours INC cortisol levels which mobilizes proteins out of muscles (probably start with structural proteins like collagen), induces proteolysis
|
|
ways that free amino acid utilization can maintain sugar level
|
gluconeogenesis and can spare glucose like lipids do that come in at acetyl CoA
|
|
cortisol does what to enzymes
|
INC the concentration of transaminases, gluconeogenesis and urea cycle, makes mRNA, blocked by eating
|
|
how long can one live with only water and electrolytes
|
about 60 days, increases to about 75 days when vitamins are taken, if one loses about 1/3 of their N, then death is irreversible
|
|
brain and glucose
|
has the greatest need for glucose, has 100% dependence on glucose, need about 70-100 mg%, needed to satisfy brain
|
|
liver and glucose
|
liver provides glucose, pancreas secretes glucagon to release glucose from glycogen, adrenal medulla releases stressed induced epinephrine which inhibits insulin release, but never use up all the glycogen in the liver,
|
|
muscle and glucose
|
is glucose sparring, adrenal medulla is stimulated to mobilize glucose from glycogen, has no glucagon receptors, prefers fatty acids, only uses glucose if anaerobic,
|
|
hormone-sensitive lipase
|
inhibited by insulin, stimulated by glucagon, epinephrine, cortisol, ACTH and GH, is lipid mobilizing (adipokinetic), turns triglycerides into FFA and glycerol, FFA then binds to albumin which cannot cross BB barrier, can enter the muscle and undergo beta-oxidation, does not enter RBC because they lack mito (which is needed for beta-oxidation)
|
|
liver and fatty acid usage
|
use some fatty acid and uses for own energy for TCA cycle, uses excess C2s to make ketones that can go to the brain, muscle and kidney, the brain shifts its glucose dependence to about 20% and ketone dependence to about 80%, same for the muscle when it uses ketones under aerobic conditions
|
|
HMG-SCoA lyase
|
once HMG-SCoA is made, lyses this C6 compound into a C2 unit (acetyl CoA) and a C4 unit (acetoacetate, a beta-keto-acid), this C4 unit can be reduced by NADH to form beta-hydroxy acid (beta-hydroxy butyrate), interchangeable with each other, these two C4 units are the ketones, the beta-hydroxy is more prevalent (80%)
|
|
do you make ketones and cholesterol at the same time?
|
NO, make cholesterol during the well-fed state, make ketones during the starvation state
|
|
how are ketones utilized in other parts of the body (brain, muscle) and not in the liver?
|
the ketones are activated with CoA by succinyl-SCoA to form an activated ketone and succinate, this is catalyzed by the enzyme succinyl CoA acetoacetate transferase which is present in tissue that use ketones but not present in the liver
1. ketone + succinyl-SCoA -> activated ketone + succinate a. catalyzed by succinyl CoA acetoacetate transferase |
|
ketotic (ketosis)
|
an excess of ketones, occurs when [glucose] is low, if acetoacetate accumulates (as occurs with excessive ketone production), can spontaneously decarboxylate into acetone which is blown off as a waste product, the accumulation of acetoacetate (along with its interchangeable form beta-hydroxy butyrate) can also lead to acidosis (ketoacidosis), acetoacetate and beta-hydroxy butyrate are acids
|
|
why can’t FAs be used to make glucose
|
because it does not give rise to a net accumulation of OAA
|
|
order of energy usage in maintaining [glucose]
|
glycogen stores -> gluconeogenesis -> adipokinesis -> proteolysis
|
|
what happens during starvation phase?
|
there is an accumulation of acetyl-CoA (C2 units), these C2 units turn on pyruvate carboxylase to turn Pyr into OAA, acetyl-CoA must be present to activate Pyr carboxylase, use fatty acids first then amino acids
|
|
cortisols role in proteolysis
|
stimulates proteolysis, glucose from breakdown of proteins, breaks down both structural (first) and enzymatic (next) proteins to INC aa available in the pool for glucose production (gluconeogenesis)
|
|
breathing and pH
|
if pH is low then breathe lots (Kussmal)
|
|
what happens in [glucose] and [ketone] levels are excessively high
|
coma
|
|
insulins effect on different parts of the body
|
liver: stimulates glycogen and fatty acid synthesis (activates acetyl-CoA synthetase), takes about 100 microU/mL
muscle: stimulates glycogen synthesis, 3-4X INC in glucose uptake, takes about 50 microU/mL adipocytes: stimulates glucose uptake and inhibits HSL, takes about 10 microU/mL for uptake and 1 microU/mL for breakdown |
|
Type I diabetes
|
don’t make insulin, used to be called juvenille onset
|
|
type II diabetes
|
tissue doesn’t respond to insulin, late onset
|
|
complications of have blood sugar at <100 microU/mL in diabetics
|
hyperglycemia-when glycogen and fatty acid aren’t made
glycosylation-glucose glycosylates proteins (albumin, hemoglobin) cataracts-reduction of glucose to glucitol, polymerizes and clouds lens microangiopathies-aneurisms, problems with capillary beds, can view this in the eye, also says if there is problem with kidney |
|
polyuria
|
lots of urine, associated with diabetes
|
|
polydipsia
|
dehydrated, drink a lot, complication of polyuria
|
|
complications of having blood sugar at <50 microU/mL
|
muscle weakness during exercise (anaerobic metabolism), this occurs because glycogen can’t be made
|
|
complications of having blood sugar at <10 microU/mL
|
hyperlipemia-INC lipids in blood and switch to ketosis
|
|
complications of having blood sugar at <1 microU/mL
|
ketosis and acidosis, inhibit HSL
|
|
glycosuria
|
excess glucose in urine
|
|
when does ketosis begin
|
6-12 hours after meal, when amino acid is beginning to be used, shift towards a gluconeogenic state
|
|
functions of amino acids
|
1. proteins-structure/enzymes/hormones/transporters/immunoglobulins
2. neurotransmitters-GLN, GLU, TYR, TRP, GLY 3. gluconeogenesis-urea cycle 4. energy-TCA cycle 5. sphingolipids-serine 6. hormones-TYR -> thryoxine, epinephrine 7. phospholipids 8. nucleotides 9. heme (gly-succinoyl-CoA) 10. vitamin B3-nicotinamide biosynthesis (TRP), niacine |
|
essential amino acids
|
FVT WIM HRLK
|
|
protein turnover
|
for insulin, half-life (T/2) is 20 mins, for dentine (teeth) and crystalline (eyes) half-life is a lifetime, on average 1-2% is degraded/24 hours, 20% of protein is excreted/degraded per day or about 30 grams loss/day (~1 oz. required for replacement 1/10 lb.), 80% is recycled
|
|
total amount of protein in body
|
~10 kg
|
|
how are amino acids loss?
|
1. can be lost intact (urea)
2. creatinine loss (Gly, Arg, Met)-~3-10 gm/day |
|
Urea
|
bulk of the amino acids loss, MW= ~60 gm/mol, 50% N
|
|
amino acids and amino acid loss
|
~15% N, therefore 15% of 30 gm of nitrogen in amino acids is lost then ~10 gms or urea is produced from 30 gm of amino acids
|
|
humans and amino acid loss
|
man usually makes ~30 gm urea/day, we ingest 90-100 gms of protein/day, total loss of about 30 gms urea, 10 gms creatinine and 40 gms total/day
|
|
protein degradation
|
no digestion occurs in the mouth, when in the stomach there is acid hydrolysis (produced from parietal cells) and pepsin (produced from chief cells as pepsinogen which is activated by high [H+]
|
|
pepsin
|
cleaves basic aa (Lys) first but fairly nonspecific (general protease), under zero order kinetics, is an inactivated pepsinogen form, when want to be activated then cleave the tail region that covers the active site which contains two Asp (which have – charge), cleavage occurs when there is protonation of one of the Asp then H2O enters and cleaves the tail with an intrinsic protease activity
|
|
rennin (chymosin)
|
used in cheese industry, when exposed to milk casein it forms a coagulated milk protein (traps milk in stomach so pepsin can work on it), found in abundant amounts in children but there is very little in adults)
|
|
what kinds of enzymes from pancreas
|
trypsinogen, chymotrphysinogen, procarboxyg-peptidase, pro-elastase, pro-collagenase
|
|
protein degradation
|
protein -> polypeptides -> smaller polypeptides -> amino peptidases -> dipeptidases -> amino acids, they then all go to the blood
|
|
enterokinase
|
activates trypsinogen to trypsin which then activates chymotrypsinogen, pro-carboxypeptidase, pro-elastase, and pro-collagenase, not a kinase but actually a protease, secreted into the lumen of the duodenum
|
|
basis of allergies
|
allergies of food due to having differences in breaking down small polypeptides, when they enter the bloodstream an allergic reaction is started
|
|
characteristics of amino acid uptake across GI mucosal cells
|
1. L amino acids only taken up because only use L
2. ATP dependent process 3. Na+ dependent and Na+ independent (some for each type, 2 different mechanisms) 4. specific transporters-(TRP and MET), if these are defective Hartnup’s Disease, basics, neutrals |
|
ubiquination
|
adding ubiquitin (76 a.a. polypeptide) to a protein and marking it for degradation, if have Asn on the NH2-end of the protein then the T/2 is short at ~20 mins, if have Met on the end, T/2 is long at ~3 days
|
|
PEST sequence
|
Proline, Glutamate, Serine, and Threonine, the more PEST sequences on a protein, the shorter the half-life because it is marked for degradation, transaminases are rich in PEST sequences, Vit B6 (pyridoxal phosphate) can block PEST sequence and protect protein from degradation, phosphorylation of serine on PEST sequence prolongs the T/2 of a molecule by blocking sites for phosphorylation
|
|
molecules with short half-lifes
|
prostaglandins and cyclo-oxygenase
|
|
which of the essential amino acids can we make
|
M, H, R, these are essential only during illness, pregnancy and growth
|
|
alanine synthesis
|
1. pyruvate (alpha-keto acid) + alpha amino acid -> alanine (alpha-amino acid) + alpha-ketoacid
a. catalyzed by transaminase (responsible for switching C=O for C-NH2 |
|
alanine transaminase (ALT)
|
catalyzes the reaction Pyr + AA -> Ala (specific) + alpha-ketoacid (generic), specific for only ½ of the reaction (Ala) generic for the other half (alpha amino acid), is very reversible with a Keq of 1
|
|
glutamate-pyruvate transaminase (GPT)
|
catalyzes the reaction Pyr + Glutamate -> alanine + alpha-keto glutarate, both halves of the reaction are specific
|
|
glutamate-oxalacetate transaminase (GOT)
|
catalyzes the reaction Glu + OAA -> alpha-ketoglutarate + Asp, both are specific
|
|
pyridoxal phosphate
|
the handle of the transaminase, needed by the transaminases, needed to carry the N from the amino acid and add it to alpha keto acid, comes from vitamin B6 (pyridoxol) which is phosphorylated with ATP to form pyridoxol-phosphate, then oxidize with NAD+ to form pyridoxal phosphate, the ATP and NAD+ steps order can be switched
|
|
schiff’s base
|
reaction between primary amine and aldehyde, found in the transaminase mechanism, occurs when the amino group reacts with the transaminase, has water leave and forms the Schiff base intermediate, water then breaks the Schiff base into an alpha keto-acid and leaves the amine on the pyridoxal phosphate (making a pyridoxamine-phosphate)
|
|
characteristics regarding transaminases
|
1. pyridoxal phosphate used in sphingolipid biosynthesis-80% of amino acid biosynthesis uses this (ser + 16:0~CoA -> sphingolipids), the co-factor
2. schiff’s base weakens bonds to alpha-carbon atom (on the amino acid on the pyridoxal phosphate) allowing: a. decarboxylation (non-oxidative)-if have C=N move to C-COOH, can weaken that bond and have decarboxylation, metal ions (esp. Ca++, Mg++) can prevent decarboxylation, can stabilize COOH and keep it on the amino acid b. beta-gamma elimination-have C=N move to R=C and then move to gamma C to weaken the bond between beta and gamma C c. deprotonation-have C=N move to C-H and have deprotonation d. transamination |
|
aspartate synthesis
|
Glu + OAA -> alpha-ketoglutarate + Asp, catalyzed by GOT, a C4, aspartate from OAA
|
|
glutamante synthesis
|
Pyr + Glu -> alpha-ketoglutarate + Ala, catalyzed by GPT, a C5, glutamate from alpha-keto glutarate
|
|
asparagine synthesis
|
1. Asp + Gln -> Asn + Glu
a. catalyzed by transamidase, tends to go forward, have to force backward, but don’t make Gln this way b. mammalian 2. Asp + NH4+ -> Asn a. catalyzed by Asn synthetase b. use ATP -> AMP + PPi -> 2 Pi c. found in prokaryotes, this enzyme is not in humans |
|
uses of asparagine
|
used in protein synthesis and not in metabolism, is glycosylated in the ER, N-linked glycosidic bond
|
|
glutamine synthesis
|
1. glutamate + NH4+ + ATP -> Gln + ADP + Pi
a. catalyzed by glutamine synthetase b. high levels of NH4+ is toxic to the body c. glutamine is more easily transported across the membrane than glutamate is d. allows for C’s to be transferred out of the cell, but it also takes a toxic NH4+ with it in a detoxified form 2. backwords reaction catalyzed by glutaminase, making Glu from Gln, not completely reversible but can go backwards, does not make ATP, releases NH4+ |
|
glutamate dehdyrogenase
|
an alternate way to make glutamate, alpha-ketoglutarate + NH4+ + NADH -> Glu, an alternative way to detoxify NH4+, reversible
|
|
liver and glutamine
|
does the reverse reactions of the muscle that converts alpha-ketoglutarate into Gln, converts Gln -> Glu + NH4+, then converts Glu -> alpha-keto glutarate + NH4+ + NADH, these two NH4+ can combine to form urea, alpha-keto glutarate enters TCA cycle and makes OAA which can be turned into glucose which leaves the liver and reenters the muscle, brain, RBC and other tissues
|
|
serine synthesis
|
glycolysis leads to 3-PGA
1. 3-PGA + NAD+ -> NADH + alpha-ketoacid 2. alpha-keto acid + amino acid (may be Glu or Asp) -> alpha keto-acid + phosphoserine a. catalyzed by a transaminase 3. phosphoserine -> serine + P |
|
glycine synthesis
|
1. from serine-
a. Ser + THF -> Gly + N5, N10 methylene THF i. catalyzed by serine hydroxy methyl transferase 2. de novo from methylene THF- a. methylene THF + CO2 + NH4+ + NADH -> glycine + NAD+ i. catalyzed by glycine synthase ii. this glycine can then be made into serine 3. from choline- a. choline is oxidized to aldehyde and oxidized to an acid, forms betaine b. betaine -> dimethylglycine + CH3 i. this methyl group can be donated to homocystein to make Met, can donate methyl via SAM to things like epinephrine, leftover becomes homo-cysteine, which can then repeat the cycle c. dimethylglycine can then lose two CH3 to 2 THF to form glycine 4. threonine-can be split into glycine and acetaldehyde (which is converted first to acetate, then to acetyl-CoA a. catalyzed by threonine aldolase |
|
tetrahydrofolate (THF)
|
composed of pteridine ring (from folate, is the two ring compound of THF), PABA (paraamino benzoic acid) and Glu (may have 5-7 of them), can pick up C’s at varying levels of oxidation, a good handle for C on intermediate oxidation levels
|
|
different forms of one carbon metabolism
|
1. methyl form-SAM (SAM can methylate Norepinephrine (from Tyr) into epinephrine)
2. alcohol, aldehyde, and acid form-THF, good handle for C on intermediate oxidation levels 3. CO2 form-biotin, can put CO2 onto something, used in pyruvate carboxylase, acetyl CoA carboxylase and propionyl CoA carboxylase |
|
Folacin
|
pteridine-PABA-glutamate (can’t make this de novo, bacteria can in our stomach)
|
|
PABA analog
|
sulfonamide, used as a way to counteract bacteria from making folacin, doesn’t hurt us, but only bacteria
|
|
methylene THF
|
can be oxidizes once to aldehyde or twice into an acid, can also be reduced to CH3, methylene THF can get 1-C donor from Ser or His (oxidized form of C as an aldehyde),
|
|
methionine synthesis
|
methionine is essential, can make it though with homocysteine + CH3 from betaine -> dimethylglycine, depends on the availiability of C’s and homocysteines, nutritional state of the body
|
|
why are there so many glycine biosynthesis pathways
|
15% of body mass = protein
1/3 of that (5%) = collagen 1/3 of that (1-2%) = glycine (1/7 of protein is glycine) |
|
cysteine synthesis
|
1. methionine + ATP -> S-Adenosyl Methionine (SAM)
a. Met attacks ATP at alpha phosphate, beta and gamma is loss as 2 Pi b. the S on SAM has three bonds with one bond to AMP and a + charge 2. SAM -> S-Adenosyl homocysteinne (SAHcys) + CH3 3. SAHcys -> adenosine (AMP) + homocysteine 4. homocysteine has two fates a. homocysteine + betaine -> methionine + dimethyl glycine b. homocysteine + serine -> cystathionine + H2O i. catalyzed by cystathionine synthase ii. attack at C bonded to OH c. cystathionine -> alpha-aminobutyrate + cysteine i. catalyzed by cystathionase |
|
tyrosine synthesis
|
1. phenylalanine + O2 -> tyrosine
a. catalyzed by mixed function oxidase (MFO), AKA is monooxygenase, brings in something reduced (THB, tetrahydrobiopterin) and oxidizes it (DHB), THB is regenerated when DHB is reduced by NADH b. half O2 goes to tyrosine other half forms H2O c. hydroxylation reaction 2. tyrosine can be used as neurotransmitters, melanin and thyroxine |
|
tetrahydrobiopterin (THB)
|
gives off 2H+ in the tyrosine synthesis reaction becoming DHB, catalyzed by phenylalanine hydroxylase (PH)
|
|
Phenylketouria (PKU)
|
individuals that have a deficient phenylalanine hydroxylase, cannot turn excess Phe into Tyr, Phe accumulates, Phe through transaminase + alpha ketoglutarate -> glutamante by phenyl pyruvate, reduction of phenyl pyruvate leads to phenyl lactate and decarboxylation of that can form phenyl acetate, these three phenyls are phenylketones, phenylketones are toxic to developing brain and heart
|
|
proline synthesis
|
1. Glu + NADH -> Schiff’s base intermediate (glutamate semi-aldehyde) + NAD+
2. glutamate semi-aldehyde + NADH -> proline a. all these reactions are reversible |
|
purposes for amino acid catabolism
|
ingestion, fasting, and starvation
|
|
liver and amino acid absorption
|
takes in 17/20, doesn’t take val, leu, ile normally, these three enter circulation and go throughout the body, after meal 60% of amino acids are val, leu, ile (branched chain amino acids
|
|
fate of branched chain amino acids (BCAA)
|
val -> succinyl-CoA
ile -> succinyl-CoA or acetyl CoA leu -> acetyl CoA succinyl CoA is used for gluconeogenesis acetyl CoA is used for TCA cycle and FA synthesis |
|
uses of BCAA during fasting/starvation
|
eat protein (98% for protein synthesis and 2% degradation), Ile and Leu contribute to FA, Ile and Val contribute to succinyl CoA which can be converted to succinate which turns ketone bodies into acetoacetyl-CoA
|
|
ACTH and cortisol
|
hypoglycemia tells the anterior portion of the pituitary gland to release ACTH, ACTH goes to the adrenal gland and tells the cortex to release cortisol and the medulla to release epinephrine, cortisol affects almost all tissues, can INC gluconeogenesis and transaminase in the liver, INC mRNA set liver up for amino acid usage, in the muscle lysosome membranes become more fragile because of cortisol, releases proteolytic enzymes that breaks down proteins into amino acids (want to get blood sugar levels up)
|
|
glucose/alanine cycle
|
the 20 a.a.’s reacted with pyruvate and transaminases to form alanine and 20 alpha-ketoacids metabolized by muscle, takes these and turns them into energy for the muscle only (spares glucose, doesn’t make it), alanine from the muscle enters the blood stream (30% of blood amino acids are Ala during starvation) and enters the liver as pyruvate, pyruvate enters gluconeogenesis become glucose and leaves the liver to supply brain, RBC
|
|
tumors in adrenal gland or pituitary
|
drives the glucose/alanine cycle so much that it leads to hyperglycemia, epinephrine is release in large amounts and blocks insulin release, INC cortisol can lead to lots of muscle wasting
|
|
glucose/glutamine cycle
|
alanine + alpha-ketoglutarate -> pyruvate and glutamate, pyruvate is used to pick up NH4+ from amino acids, glutamate builds up but cannot leave the muscle, some glutamate loses NH4+ and replenishes alpha-ketoglutarate (through GDH), some glutamate is also turned into Gln with NH4+ which can leave the muscle cell (through Gln synthetase), 20% of blood amino acids is glutamine, goes to liver and the liver turns it into glucose
|
|
fate of N atoms from amino acuds
|
1. alanine-alanine that enters the liver can be converted (with alpha-keto glutarate) to pyruvate and glutamate (through GPT), glutamate (through GDH) can replenish GDH and release NH4+
2. glutamine-can be turned into Glu through glutaminase and release NH4+, Glu can be turned into alpha-ketoglutarate and also release NH4+, this ammonia builds up and is detoxified and excreted, intestinal mucosa can excrete NH4+ and kidney pisses out some NH4+ |
|
Urea Cycle
|
occurs in the liver, partly in the mito, partly in the cyto
1. NH4+ + CO2 + 2 ATP -> Carbomyl phosphate + 2 ADP + Pi a. catalyzed by carbamoyl-phosphate synthetase (CPS-1), mito 2. carbamoyl phosphate + ornithine -> citrulline + Pi a. catalyzed by ornithing transcarbamoylase (OTC), mito 3. citrulline + Asp + ATP -> AMP + 2Pi + arginosuccinate a. catalyzed by arginosuccinate synthetase (ASS), cytosol 4. arginosuccinate -> fumarate (C4) + arginine a. catalyzed by arginosuccinate lyase (ASL), cytosol 5. arginine + H2O -> urea + ornithine a. catalyzed by arginase, cytosol, renenters the mito |
|
citrulline
|
has the ability to leave the mito and enter the cytosol of the lvier
|
|
arginine
|
although it is essential, can be made in the body depending on the nutritional values
|
|
notes regarding urea cycle
|
1. occurs in two compartments
2. enzyme-induced during starvation (by cortisol) 3. two nitrogens (from NH4+ and from aspartate) 4. fumarate links urea cycle to the TCA cycle, also a source of H+ pickerupers, fumarate to malate, malate to OAA, OAA to aspartate 5. requires catalytic amounts of ornithine 6. provides pathway for arginine biosynthesis 7. each urea made utilizes 4 ATP (2 at CPS-1, 2 at arginosuccinate synthetase step) 8. disease at each step are known |
|
fate of alanine
|
alanine -> pyruvate via ALT (GPT)
|
|
fate of serine
|
ser -> glycine via THF; serine hydroxyl methyl transferase
ser -> pyruvate + H2O + NH4+ via serine dehdyratase ser -> cystein via cystathionine ser -> phsophatidyl serine (-> ethanolamine, choline), sphingolipids (palmitoyl CoA + serine |
|
fate of glycine
|
gly -> ser via serine hydroxyl methyl transferase
gly -> CO2, THF, NH4+, NADH via glycine synthase (or glycine cleavage enzyme) gly -> glyoxalate -> oxalate |
|
fate of aspartate
|
asp -> OAA via GOT
|
|
fate of asparagine
|
asn -> excreted
|
|
fate of glutamate
|
glu + NAD+ -> NH4+ + NADH + alpha-keto glutarate via GDH
|
|
fate of glutamine
|
gln -> glu + NH4+ via glutaminase
|
|
fate of proline
|
pro -> glu -> alpha-keto glutarate (the reverse of synthesis)
|
|
fate of phenylalanine
|
phe -> tyr via phenylalanine hydroxylase
|
|
fate of tyrosine
|
tyr -> homogentisic acid (catecholamines, melanin, DOPA, energy)
tyr + alpha-keto glutarate -> alpha-ketoacid (parahydroxy phenylpyruvate) alpha-ketoacid (parahydroxy phenylpyruvate) + O2 -> CO2 + homogentisic acid via Vit C parahydroxy phenylpyruvate -> fumarate + acetoacetate (both ketogenic and glucogenic) parahydroxy phenylpyruvate -> polymer (is black in urine, alcaptonuria) |
|
fate of arginine
|
arginine -> ornithine + urea
ornithine + alpha keto glutarate -> semialdehyde + glutamate via transaminase semialdehyde -> glutamate glutamate -> alpha keto glutarate via GDH |
|
fate of threonine
|
1. threonine -> alpha-ketobutyrate
a. threonine dehydratase 2. alpha-ketobutyrate + CoAsh -> propionyl-CoA + CO2 3. propionyl-CoA + CO2 + biotin -> methyl malonyl CoA a. carboxylase 4. methyl malonyl CoA -> succinyl-CoA a. B12 mutase |
|
alternative fate of threonine
|
threonine -> glycine + acetaldehyde via threonine aldolase, the acetaldehyde then becomes acetate then finally acetyl-CoA
|
|
which amino acids enter at the pyruvate level
|
Pyruvate (C3)-ala, ser, gly, cys, trp, thr
|
|
which amino acids enter at the acetyl-CoA level
|
acetyl-CoA (C2)-thr, leu, ilu
|
|
which amino acids enter at the acetoacetate level
|
acetoacetate (C4) -> acetyl CoA, amino acids are phe, tyr, trp, lys
|
|
which amino acids enter at the succinyl-CoA level
|
succinyl-CoA (C4)-thr, met, ile, val
|
|
which amino acids enter at the fumarate level
|
fumarate (C4)-asp, phe, tyr
|
|
which amino acids enter at the OAA level
|
OAA (C4)-Asp
|
|
fate of methionine
|
1. Met + ATP -> SAM
2. SAM -> CH3 (which can be donated) + S(A) Hcys 3. S(A) Hcys -> AMP + Hcys 4. Hcys + Ser -> cystathionine a. catalyzed by cystathionine synthase 5. cystationine -> cysteine + precursor to alpha-ketobutyrate a. catalyzed by cystathioninase |
|
fate of cysteine (through reduction)
|
two cysteines are joined together by a cysteine bond, responsible for forming pyruvate and H2S
1. proteolysis of a protein -> cystine 2. cystine -> reduced form of cysteine a. catalyzed by cystine reductase 3. reduced form of cystine -> mercaptor pyruvate a. catalyzed by transamination 4. mercapto pyruvate + 2H+ -> pyruvate + H2S |
|
fate of cysteine (through oxidation)
|
responsible for forming pyruvate and SO4- as a source of sulfur
1. cysteine + O2 -> oxidized form of cysteine a. catalyzed by dioxygenase 2. oxidized form of cysteine -> pyruvate-SO2 a. catalyzed by transaminase 3. pyruvate-SO2 -> pyruvate + SO3- (sulfite, which can be converted to sulfate (SO4--)) |
|
uses for S
|
need for CoASH, sulfates used in sulfatides, glycoaminoglycans, conjugation reactions (makes things more soluble)
|
|
examples of glycosaminoglycans
|
chondroitin sulfate, dermatan sulfate, kertan sulfate, heparin sulfate
|
|
examples of conjugation reactions
|
bilirubin, hormones, DHEA-S (the stored form of DHEA)
|
|
how is sulfate trapped?
|
form 3’-Phospho adenosyl 5’phospho Sulfate (PAPS), the activated form for sulfate (need 3 ATPs to make)
1. SO4 + ATP -> Adenosyl Phosphosulfate (APS) + 2 PPi (-> 2Pi) 2. APS + ATP -> PAPS + ADP |
|
fate of histidine
|
1. decarboxylation
a. histidine -> CO2 + histamine (catalyzed by histidine decarboxylase) 2. forming glutamate a. histidine -> NH4+ + urocanic acid (has conjugated double bonds and can observe uv light) i. catalyzed by histidase b. urocanic acid + H2O -> FIGLU (formiminoglutamate, composed of glutamate and formimino) (intermediate that has opened ring, found in urine if there is a deficiency in folic acid) i. catalyzed by urocanase c. FIGLU + THF -> glutamate + formimino-THF |
|
fate of trytophane
|
1. tryptophane + O2 -> kynurenine (open ring)
a. catalyzed by dioxygenase 2. kynurenine is then modified by: a. remove formate (HCOOH) b. remove alanine (and convert to pyruvate, glucogenic) c. deaminate (NH2) d. decarboxylate (CO2) e. break ring open with O2 (forms C6 cleaving the benzoic acid), forms alpha-ketoadipic acid f. oxidative decarboxylation (add SCoA at one end, lose 2 CO2 at both ends) (forms acetoacetyl-SCoA, ketogenic) |
|
fate of lysine
|
1. ketogenic
a. lysine + alpha-ketoglutarate -> saccharopine b. saccharopine -> NH4+ + alpha-amino adipic acid c. alpha-amino adipic acid -> NH4+ + alpha-keto adipic acid i. catalyzed by transaminase d. alpha-ketoadipic acid turns into acetoacetyl-CoA via oxidative decarboxylation (add SCoA at one end, lose 2 CO2 at both ends) (forms acetoacetyl-SCoA, ketogenic) 2. glucogenic a. slightly glucogenic, lysine is more ketogenic though, an alternate path that we do not need to know about |
|
common steps of the branched chain amino acids (BCAA)
|
1. VAL, ILE, LEU undergo transamination first to form branched chain alpha-ketoacids
2. then undergo oxidative decarboxylation to form a completely reduced C with a CoA on the end, acts like a branched cahin fatty acid 3. then undergo the 1st step of beta oxidation (the addition of FAD and add a double bond between the alpha and beta C) |
|
valine after the common steps of BCAA
|
1. valine undergoes 3 steps and forms intermediate
2. intermediate undergoes oxidation of C=C to COOH and forms methyl malonyl-SCoA 3. methyl malonyl-SCoA -> succinyl-SCoA a. catalyzed by methyl malonyl mutase with a vitamin B12 cofactor |
|
isoleucine after the common steps of BCAA
|
1. valine undergoes 3 steps and forms intermediate
2. continue with beta-oxidation and add another CoASH to form propionyl-SCoA and acetyl CoA (ketogenic) 3. propionyl-SCoA + CO2 + biotin + ATP -> methyl malonyl CoA 4. methyl malonyl CoA -> succinyl-SCoA (glucogenic) |
|
leucine after the common steps of BCAA
|
1. leucine undergoes 3 steps and forms intermediate
2. intermediate is carboxylated with CO2 to form an intermediate 3. that intermediate is split with H2O to form acetyl-CoA and acetoacetate (beta-ketobutyrate, forms 2 acetyl-CoA) 4. LEUCINE IS THE ONLY AMINO ACID THAT IS STRICTLY KETOGENIC |
|
Maply Syrup Urine Disease
|
is related to Val, Ile and Leu, genetic defect in decarboxylation step, destroys brain, test urine for branched chain a.a., tell them not to eat Val, Ile, or Leu
|
|
Functions of Nucleotides
|
1. nucleic acids (DNA, RNA)
2. Energy forms (NMP, NDP, NTP) 3. regulatory (2nd messengers-cAMP, cGMP) 4. activators (UDP-glucose, galactose; CDP-Choline 5. NAD, FAD, CoA, PAPS, SAM (cofactors) 6. Adenylations (for regulation) 7. physiological agents (Adenosine, ATP, ADP released with neurotransmitters), has a direct effect on smooth muscles |
|
nucleosides
|
base + sugar
|
|
nucleotides
|
base + sugar + PO4
|
|
structures
|
know them 242-243
|
|
purines
|
two rings, adenine, guanine, hypoxanthine (precursor for xanthine), xanthine, uric acid
|
|
pyrimidines
|
one ring, cytosine, uracil, thymine, orotic acid
|
|
names of the bases, nucleosides and nucleotides
|
adenine + sugar -> adenosine + PO4 -> adenylate
guanine + sugar -> guanosine + PO4 -> guanylate hypoxanthine + sugar -> inosine + PO4 -> inosinate xanthine + sugar -> xanthosine + PO4 -> xanthylate cytosine + sugar -> cytidine + PO4 -> cytidylate uracil + sugar -> uridine + PO4 -> uridylate thymine + sugar -> thymidine + PO4 -> thymidylate orotic acid + sugar -> orotidine + PO4 -> orotidylate |
|
deoxyribose vs. ribose
|
alpha-D-deoxyribose is missing an OH on 2 C, alpha-D-ribose undergoes a reduction process
|
|
glycosidic bond
|
for purines is a beta N-glycoside bond between 9-N on purine and 1’C on the ribose
for pyrimidines is a beta N-glycoside bond between 1-N on pyrimidine and 1’C on the ribose |
|
phosphorylation of the bases
|
can occur on OH of C 2, 3, or 5, but normally not on 1 position
|
|
phosphodiester bond
|
connects nucleotides, is a 3’-5’ bond
|
|
where do the atoms from nucleotide biosynthesis come from
|
memorize, pg 245, biosynthesis occurs during the well fed state, need ribose and energy
|
|
Purine synthesis
|
1. glucose -> ribose-5-phosphate
a. via HMPS 2. ribose-5-phosphate + ATP -> phosphoribosyl pyrophosphate (PRPP) + AMP a. catalyzed by pyrophosphoribosyl kinase 3. PRPP + Gln -> Glu + PPi (-> 2Pi) + phosphoribosylamine (PR-NH2) a. catalyzed by Gln-PRPP amidotransferase 4. PR-NH2 + Gly + ATP -> Phosphoribosyl-glycinamide + ADP + Pi a. catalyzed by phosphoribosyl glycinamide synthetase 5. phosphoribosyl-glycinamide + formyl-THF (the CH2 is oxidized to CHO) -> intermediate a. catalyzed by transformylase, if short on folate will have problems with biosynthesis here 6. intermediate + gln + ATP -> intermediate + ADP + Pi 7. intermediate -> intermediate (cyclized form) a. catalyzed by a cyclase 8. intermediate + CO2 -> intermediate a. does not use biotin and ATP, catalyzed by a carboxylase 9. intermediate + Asp + ATP-> intermediate + fumarate + ADP + Pi a. catalyzed by a synthetase 10. intermediate + formyl-THF (as a oxidized CHO, recycled with serine -> gly) -> intermediate a. a formylation 11. intermediate -> cyclization of intermediate forming inosine mono phosphate (IMP), it is a hypoxanthin ring, the first purine nucleotide |
|
inhibition of pyrophosphoriboxyl kinase
|
inhibited by high [ADP] and hi [GDP] concentration, this is a sign of low energy
|
|
importance of the step catalyzed by Gln-PRPP amidotransferase
|
is the key regulatory (commited step of purine synthesis)
|
|
regulation of Gln-PRPP amidotransferase
|
inhibition-products of NMP, NDP, NTP (feedback), especially A and G, is additive, A and G inhibiton add together
stimulation-high PRPP (feed forward) mechanism-doesn’t follow Michaelis-Menten, is sigmoidal shape due to substrate activation or cooperativity, INC velocity with INC in PRPP, shifts to the right in the presence of purine nucleotides (shows a slowing velocity) |
|
characteristics of de novo purine synthesis
|
1. there is a sugar handle (PRPP)
2. linear pathway to IMP (branched thereafter) 3. 5 ATP’s required 4. 2 Gln, 2 THF (serines), glycine, CO2, aspartate required 5. highly regulated (2 of them, the key is the formation of PR-NH2, other is creation of PRPP) |
|
adenine synthesis
|
1. IMP + Aspartate + GTP -> succinyl adenine
2. succinyl adenine + GTP -> adenine (AMP) + succinate a. adenine acts as an inhibitor of the key regulatory step in the pathway |
|
guanine synthesis
|
1. IMP + NAD+ -> xanthinic acid (XMP) + NADH
a. acts as a way to activate the molecule 2. XMP + ATP + Gln -> guanine (GMP) + Glu |
|
reciprocal regulation of purine synthesis
|
ATP blocks A synthesis and stimulates G synthesis, GTP blocks G synthesis and stimulates A synthesis, they reciprocally act as energy source for the other reaction
|
|
pyrimidine synthesis
|
1. Gln + CO2 + P (from 2 ATP -> 2 ADP + Pi) -> carbamoyl-phosphate
a. catalyzed by carbamoyl phosphate-II (CPS-II) 2. carbamoyl-phosphate + Asp -> Pi + intermediate (ready for cyclization) a. catalyzed by aspartate trans carbamoylase (ATCase) 3. intermediate -> dihydro-orotic acid (cyclized form) 4. dihydro-orotic acid + NAD+ -> orotic acid + NADH a. the orotic acid has a double bond between CH and C-COOH 5. orotic acid + PRPP -> orothodylate (OMP) |
|
carbamoyl-phosphate II (CPS-II)
|
the key commited step in pyrimidine synthesis, not in mito like in urea cycle, but in the cytosol, activated by ATP (high energy charge), stimulated by PRPP, inhbitied by UMP (1st pyrimidine product)
|
|
aspartate trans carbamoylase
|
also a committed step, is inhibited by CTP (last pyrimidine product)
|
|
uracil synthesis
|
OMP -> UMP + CO2
catalyzed by orotidylate decarboxylase, UMP is used to inhibit CPS-II can then be phosphorylated by two ATPs to form UTP, |
|
CTP synthesis
|
UTP + ATP + Gln -> CTP + Glu + ADP + Pi
catalyzed by cytidylate synthetase |
|
notes for pyrimidine synthesis
|
is completely a linear a pathway and the sugar handle is added after the ring is formed
|
|
thymine biosynthesis
|
ribose needs to be converted to deoxyribose before uracil nucleotide can be methylated to thymine
|
|
ribonucleotide reductase
|
Ribose + thioredoxin (has 2 reduced cys) -> 2’-deoxyribose + oxidized form of thioredoxin
catalyzed by ribonucleotide reducatse, requires diphosphate level of nucleotide substrate (not tri- or mono-), must then recycle to get back reduced thioredoxin, use flavoprotein and thioredoxin reductase and oxidize FADH2 to FAD, must then recycle to get back FADH2, use the flavoprotein again and oxidize NADPH to NADP+ to get back FADH2, must the regenerate NADPH and that comes from HMPS and malic enzyme |
|
formation of dTMP
|
1. via d-UMP
a. UTP -> UDP + Pi b. UDP -> dUDP i. catalyzed by ribonucleotide reductase c. dUDP + ATP -> dUTP + ADP d. dUTP -> dUMP + PPi (-> 2Pi) e. dUMP -> dTMP (through methylation by thymidylate synthase) 2. via d-CDP a. CTP -> CDP + Pi b. CDP -> dCDP i. catalyzed by ribonucleotide reductase c. dCDP -> dUMP + NH4+ + Pi (through deaminase and phosphatase) |
|
thymidylate synthase
|
does methylation of dUMP into dTMP, uses methylene-THF and adds CH3 to dUMP, this CH3 is reduced and methylene THF is itself oxidized to dihydrofolate, THF is remade when DHF is reduced to THF by dihydrofolate reductase (uses NADPH and gives off NADP+), this is inhibited by methotrexate (MTX, acts as an analogue to DHF)
|
|
cancer patients
|
block thymine biosynthesis in cancer patient, blocks the reformation of THF, why chemotherapy is so crazy, hair and gut regenerate fast and affected by these things
|
|
relationship between purines and pyrimidines
|
PRPP can turn on both purine and pyrimidine synthesis, ATP can also stimulate pyrimidine synthesis
|
|
regulation of ribonucleotide reductase
|
acts as a switch, on when [ATP] is high, off when [dATP] is high, on form has INC binding affinity for ribonucleotide reductase for CDP and UDP, dTTP is made from both dCDP and dUDP, dTTP inhibits both CDP and UDP to deoxy forms and stimulates GDP to dGDP form, dGTP is then made and inhibits GDP to dGPD and stimulates ADP to dADP, dATP is made and turns the system off
|
|
degradation of DNA and RNA
|
1. DNA and RNA -> nucleotides
a. via nucleases and phosphodiesterases 2. nucleotides (monophosphates) -> nucleosides + Pi a. via phosphatase 3. nucleosides + Pi -> base + sugar a. via phosphorylase 4. sugar -> ribose-1-P or dexoy-R |
|
salvage of the degradation of DNA and RNA
|
1. sugar-ribose-1-P can be salvaged as ribose-5-P through a phosphoribo mutase, ribose-5-P can then enter HMPS (consume sugar) or PRPP (salvage them and reuse them)
2. base-handled differently for purines and pyrimidines 3. nucleosides-not always reused, can but not always 4. nucleotides-reused |
|
pyrimidine salvage
|
is readily done, add PRPP to the pyrimidines taken in (O.A., Cyto, Uracil) and form (OMP, CMP, UMP), PRPP added to ring after ring is formed, thymine is not salvaged, if thymine and PRPP were added together would get ribose-thymine but ribonucleotide reductase would not act on this substrate
|
|
purine salvage
|
must use different enzymes for A and G and HX, PRPP is added to A to make AMP catalyzed by adenine-phosphoribosyl transferase (A-PRT), PRPP is added to G or HX to form GMP or IMP and this is catalyzed by G/HX-PRT, this is also catalyzed by guanine-hypoxanthine phosphoribosyl transferase
|
|
cytosine (and uracil) degradation
|
1. cytosine loses NH4+ and O2 is added to form uracil
2. uracil undergoes reduction with NAD(P)H to form dihydro-Uracil 3. dihydro-uracil undergoes cleavage to form ureidopropionate (AKA carbamoyl-beta-alanine) 4. carbamoyl-beta-alanine loses NH4+ and CO2 to form beta alanine 5. beta alanine can be turned into acetyl-CoA |
|
uracil synthesis
|
OMP -> UMP + CO2
catalyzed by orotidylate decarboxylase, UMP is used to inhibit CPS-II can then be phosphorylated by two ATPs to form UTP, |
|
CTP synthesis
|
UTP + ATP + Gln -> CTP + Glu + ADP + Pi
catalyzed by cytidylate synthetase |
|
notes for pyrimidine synthesis
|
is completely a linear a pathway and the sugar handle is added after the ring is formed
|
|
thymine biosynthesis
|
ribose needs to be converted to deoxyribose before uracil nucleotide can be methylated to thymine
|
|
ribonucleotide reductase
|
Ribose + thioredoxin (has 2 reduced cys) -> 2’-deoxyribose + oxidized form of thioredoxin
catalyzed by ribonucleotide reducatse, requires diphosphate level of nucleotide substrate (not tri- or mono-), must then recycle to get back reduced thioredoxin, use flavoprotein and thioredoxin reductase and oxidize FADH2 to FAD, must then recycle to get back FADH2, use the flavoprotein again and oxidize NADPH to NADP+ to get back FADH2, must the regenerate NADPH and that comes from HMPS and malic enzyme |
|
formation of dTMP
|
1. via d-UMP
a. UTP -> UDP + Pi b. UDP -> dUDP i. catalyzed by ribonucleotide reductase c. dUDP + ATP -> dUTP + ADP d. dUTP -> dUMP + PPi (-> 2Pi) e. dUMP -> dTMP (through methylation by thymidylate synthase) 2. via d-CDP a. CTP -> CDP + Pi b. CDP -> dCDP i. catalyzed by ribonucleotide reductase c. dCDP -> dUMP + NH4+ + Pi (through deaminase and phosphatase) |
|
thymidylate synthase
|
does methylation of dUMP into dTMP, uses methylene-THF and adds CH3 to dUMP, this CH3 is reduced and methylene THF is itself oxidized to dihydrofolate, THF is remade when DHF is reduced to THF by dihydrofolate reductase (uses NADPH and gives off NADP+), this is inhibited by methotrexate (MTX, acts as an analogue to DHF)
|
|
cancer patients
|
block thymine biosynthesis in cancer patient, blocks the reformation of THF, why chemotherapy is so crazy, hair and gut regenerate fast and affected by these things
|
|
relationship between purines and pyrimidines
|
PRPP can turn on both purine and pyrimidine synthesis, ATP can also stimulate pyrimidine synthesis
|
|
regulation of ribonucleotide reductase
|
acts as a switch, on when [ATP] is high, [dATP] is high, on form has INC binding affinity for ribonucleotide reductase for CDP and UDP, dTTP is made from both dCDP and dUDP, dTTP inhibits both CDP and UDP to deoxy forms and stimulates GDP to dGDP form, dGTP is then made and inhibits GDP to dGPD and stimulates ADP to dADP, dATP is made and turns the system off
|
|
degradation of DNA and RNA
|
1. DNA and RNA -> nucleotides
a. via nucleases and phosphodiesterases 2. nucleotides (monophosphates) -> nucleosides + Pi a. via phosphatase 3. nucleosides + Pi -> base + sugar a. via phosphorylase 4. sugar -> ribose-1-P or dexoy-R |
|
salvage of the degradation of DNA and RNA
|
1. sugar-ribose-1-P can be salvaged as ribose-5-P through a phosphoribo mutase, ribose-5-P can then enter HMPS (consume sugar) or PRPP (salvage them and reuse them)
2. base-handled differently for purines and pyrimidines 3. nucleosides-not always reused, can but not always 4. nucleotides-reused |
|
pyrimidine salvage
|
is readily done, add PRPP to the pyrimidines taken in (O.A., Cyto, Uracil) and form (OMP, CMP, UMP), PRPP added to ring after ring is formed, thymine is not salvaged, if thymine and PRPP were added together would get ribose-thymine but ribonucleotide reductase would not act on this substrate
|
|
purine salvage
|
must use different enzymes for A and G and HX, PRPP is added to A to make AMP catalyzed by adenine-phosphoribosyl transferase (A-PRT), PRPP is added to G or HX to form GMP or IMP and this is catalyzed by G/HX-PRT, this is also catalyzed by guanine-hypoxanthine phosphoribosyl transferase
|
|
cytosine (and uracil) degradation
|
1. cytosine loses NH4+ and O2 is added to form uracil
2. uracil undergoes reduction with NAD(P)H to form dihydro-Uracil 3. dihydro-uracil undergoes cleavage to form ureidopropionate (AKA carbamoyl-beta-alanine) 4. carbamoyl-beta-alanine loses NH4+ and CO2 to form beta alanine 5. beta alanine can be turned into acetyl-CoA |
|
thymine degradation
|
thymine -> di-hydrothymine -> beta-amino isobutyric acid -> lose NH4+ and CO2 (carbomyl is lost), then lose another NH4+ to form methyl malonyl CoA, methyl malonyl CoA is formed into succinyl-CoA with B12 mutase
|
|
adenosine degradation
|
1. adenosine -> inosine + NH4+
a. catalyzed by adenosine deaminase (A.D.A.) 2. inosine + Pi -> hypoxanthine + R-1-P 3. hypoxanthine + O2 -> xanthine + H2O2 a. catalyzed by xanthine oxidase (X.O.) b. H2O2 is recycled to O2 via catalase 4. xanthine + O2 -> uric acid + H2O2 a. catalyzed by xanthine oxidase (X.O.) b. H2O2 is recycled to O2 via catalase 5. uric acid is excreted |
|
guanosine degradation
|
1. guanosine + Pi -> guanine + R-1-P
a. catalyzed by purine nucleoside phosphorylase 2. guanine + H2O -> xanthine + NH4+ a. catalyzed by guanase 3. xanthine -> uric acid a. catalyzed by xanthine oxidase 4. uric acid is excreted |
|
Gout
|
uric acid (less soluble) <-> enol <-> urate (more soluble), the uric acid that is less soluble will prevail at low pH and will precipitate in tissues, forms needle-like crystals form in synovial fluid leading to gout
|